
Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Description
Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Summary
GlobalData, the industry analysis specialist, has released its latest report “Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Denmark’s pharmaceutical and biotechnology industries are among the largest and most advanced in the world as they offer attractive economic prospects to various local and multinational companies, including cooperative R&D initiatives, locations for European headquarters, and strategic partnerships. The availability of a highly automated and sophisticated pharmaceutical and biotech production landscape, a friendly corporate climate, and a top-notch research environment, among others, promote the expansion of pharmaceutical manufacturing facilities in Denmark. In terms of US dollars, Denmark’s pharmaceutical market increased from $3.3 billion in 2015 to $3.9 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 3.5%. It was forecast to increase to $4.0 billion in 2021. In terms of Danish Krone (DKK), Denmark’s pharmaceutical market increased from DKK21.9 billion in 2015 to DKK25.3 billion in 2020, at a CAGR of 2.9%. It was forecast to increase to DKK26 billion in 2021. Denmark is one of Europe's top countries for medical technology. It offers attractive collaborations in R&D, design and innovation expertise, test and demonstration facilities, public-private partnerships, and high-tech manufacturing. In 2016, the medical devices market in Denmark was worth $1.4 billion, which increased at a CAGR of 6.3% to $1.9 billion in 2021. In 2021, the Danish government revealed its new life sciences industrial strategy, comprising 38 new projects across seven major industries. The strategy emphasized improving the environment for R&D and using health data, as well as securing a highly educated workforce and laying the framework for the country's industry's worldwide expansion, which aimed to benefit Denmark’s patients and economy.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes -
This report will enhance your decision-making capability by allowing you to -
Summary
GlobalData, the industry analysis specialist, has released its latest report “Denmark Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Denmark’s pharmaceutical and biotechnology industries are among the largest and most advanced in the world as they offer attractive economic prospects to various local and multinational companies, including cooperative R&D initiatives, locations for European headquarters, and strategic partnerships. The availability of a highly automated and sophisticated pharmaceutical and biotech production landscape, a friendly corporate climate, and a top-notch research environment, among others, promote the expansion of pharmaceutical manufacturing facilities in Denmark. In terms of US dollars, Denmark’s pharmaceutical market increased from $3.3 billion in 2015 to $3.9 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 3.5%. It was forecast to increase to $4.0 billion in 2021. In terms of Danish Krone (DKK), Denmark’s pharmaceutical market increased from DKK21.9 billion in 2015 to DKK25.3 billion in 2020, at a CAGR of 2.9%. It was forecast to increase to DKK26 billion in 2021. Denmark is one of Europe's top countries for medical technology. It offers attractive collaborations in R&D, design and innovation expertise, test and demonstration facilities, public-private partnerships, and high-tech manufacturing. In 2016, the medical devices market in Denmark was worth $1.4 billion, which increased at a CAGR of 6.3% to $1.9 billion in 2021. In 2021, the Danish government revealed its new life sciences industrial strategy, comprising 38 new projects across seven major industries. The strategy emphasized improving the environment for R&D and using health data, as well as securing a highly educated workforce and laying the framework for the country's industry's worldwide expansion, which aimed to benefit Denmark’s patients and economy.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Denmark, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, GlaxoSmithKline (GSK), Sanofi, Novo Nordisk, and Leo.
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Zimmer Biomet, Getinge, and Coloplast.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the Danish healthcare market.
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
159 Pages
- Key Highlights: Facts About the Danish Healthcare Market
- Key Highlights: Healthcare Startups in Denmark
- Key Events: Danish Healthcare Industry, 2016-22
- Key Events: Denmark Pharmaceutical Market
- Key Events: M&As, VC, and PE Deals, Global Pharmaceutical Market, 2021-22
- Key Events: Top Completed Deals by Value, 2022
- Country Profile, Denmark, 2022
- Pharmaceutical Market - Overview
- Pharmaceutical Market - Exports
- Pharmaceutical Market - Imports
- Pharmaceutical Market - Supply Channels, Denmark
- Pharmaceutical Market - Market Segments
- Pharmaceutical Market - Market Segment, Generic Drugs, Denmark
- Pharmaceutical Market - Market Segments, Biologics and Biosimilars, Denmark
- Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Denmark
- Major Therapeutic Areas, Denmark
- COVID-19 Epidemiology, Denmark
- COVID-19 Impact and Developments, Denmark
- COVID-19 Impact and Developments in the Healthcare Market, Denmark
- COVID-19 Clinical Trials Landscape, Denmark
- Pharmaceutical Market - Major Players
- Medical Devices Market - Overview
- Medical Devices Market - Major Segments
- Medical Devices Market - Hospital Supplies Market
- Medical Devices Market - Wound Care Management Market
- Medical Devices Market - Cardiovascular Devices Market
- Medical Devices Market - Orthopedic Devices Market
- Medical Devices Market - General Surgery Devices Market
- Medical Devices Market - Diagnostics Market
- Medical Devices Market - Major Players
- Drivers and Barriers
- Deal Analysis: Pharmaceutical Market, Denmark, 2020-22
- Deal Analysis: Medical Devices Market, Denmark, 2020-22
- HealthTech Landscape, Denmark
- HealthTech Deals Landscape, Denmark
- Key HealthTech Deals, Denmark
- Adoption of Technology in Healthcare, Denmark
- Digital Statistics, Denmark
- Digital Health Regulations, Denmark
- HealthTech Landscape: Benefits and Risks, Denmark
- Overview of Healthcare System, Denmark
- Reimbursement Process, Denmark
- Overview of Insurance Providers, Denmark
- Healthcare Spending and Pharmaceutical Price Index, Denmark
- Pricing Policies, Denmark
- Overview of Regulatory Agencies, Denmark
- Marketing Authorization for Pharmaceutical Products, EU
- Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Denmark
- Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Denmark
- Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Denmark
- Marketing Authorization for Pharmaceutical Products, National Procedure, Denmark
- Marketing Authorization for Pharmaceutical Products, Denmark
- Marketing Authorization for Medical Devices, Denmark
- Intellectual Property Rights, Patent, Denmark
- Intellectual Property Rights, Trademark, Denmark
- Clinical Trial Regulations, Denmark
- Pharmaceutical Clinical Trials Landscape, Denmark
- Medical Devices Clinical Trials Landscape, Denmark
- Exports and Imports Regulations, Denmark
- Pharmacy License Regulations, Denmark
- Online Pharmacy Regulations, Denmark
- Pharmaceutical Advertising Regulations, Denmark
- Labeling and Packaging Regulations, Denmark
- Denmark Healthcare Policy Highlights
- Healthcare Facilities, Denmark
- Life Expectancy and Immunization Rates, Denmark
- Environmental Health, Denmark
- Healthcare Personnel, Denmark
- Disease Burden, Denmark
- Healthcare Expenditure, Denmark
- Healthcare Spending Components and Pharmaceutical Spending, Denmark
- Trade Associations, Denmark
- Trade Fairs, Denmark
- Opportunities and Challenges
- Research Methodology
- About GlobalData
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.